NEWS

Early Chemo to Prevent Ovarian Cancer Recurrence Fails to Increase Survival

A large study has found that women in remission for ovarian cancer who started chemotherapy to prevent a recurrence based on blood levels of the protein CA125 did not live longer than women who started chemotherapy only after symptoms of the disease arose.

The findings, several gynecologic cancer experts said, should influence clinical practice and make clinicians rethink how they monitor patients for recurrence and initiate additional treatments, or salvage therapies. Read more > >

• Lung Cancer Screening Leads to High Rates of False Positives

  Study finds that use of computed tomography led to high rates of follow-up testing

• Combo Treatment Boosts Survival in Biliary Tract Cancers

  Gemcitabine plus cisplatin may be new standard of care for advanced disease

• Breast Cancer Drug Helps Patients with Gastric Cancer

  Adding trastuzumab to chemotherapy modestly improved overall survival

• HPV Status Can Predict Outcome in Oropharyngeal Cancer

  Determining HPV status helps predict treatment response and may become routine

• Bevacizumab Does Not Prevent Recurrence of Colorectal Cancer

  The angiogenesis inhibitor delayed but did not prevent recurrence in a phase III trial

• Drugs that Inhibit DNA Repair May Treat Advanced Breast Cancer

  Results from two phase II trials of PARP inhibitors show promise

• Radiofrequency Ablation Effective Against Barrett Esophagus

  Using radio waves to heat and destroy abnormal cells may be an alternative to surgery

• Exposure to PCBs In the Home May Increase Risk of Childhood Leukemia

  Researchers measured chemical levels in the home and examined risk of ALL